Skip to main content

Vascular 2023 Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Clinical Science

Clinical Science

Type here to filter the list

(VP013) ASSOCIATIONS OF MATERNAL GESTATIONAL DIABETES WITH OFFSPRING DIABETES ACROSS TWO PREGNANCIES: PRELIMINARY WORK

Favorite
(VP060) IDENTIFICATION OF PAM AS NOVEL MONOGENIC DIABETES GENE

Favorite
(VP082) PHARMACEUTICAL TREATMENT OF GESTATIONAL DIABETES MELLITUS AND OBSTETRICAL INTERVENTIONS AND NEONATAL OUTCOMES: A POPULATION-BASED STUDY IN CANADA

Favorite
(VP084) POPULATION HEALTH VALUE OF BEING IN TARGET: RESULTS FROM THE CANADIAN MULTI-MORBIDITY MODEL FOR TYPE 2 DIABETES

Favorite
(VP108) THE ASSOCIATION BETWEEN PRE-EXISTING DIABETES AND STILLBIRTH AND PERINATAL MORTALITY: A SYSTEMATIC REVIEW AND META-ANALYSIS

Favorite
(VP129) VARIOUS COMBINATIONS OF GESTATIONAL DIABETES AND GESTATIONAL HYPERTENSION IN TWO PREGNANICES AND ASSOCIATIONS WITH CARDIOVASCULAR DISEASE

Favorite
(DCP068) A COMPARATIVE STUDY ON THE USE OF GLUCOSE-LOWERING AGENTS AS ADJUVANT THERAPY IN PATIENTS WITH TYPE 1 DIABETES MELLITUS

Favorite
(DCP069) ALLEVIATION OF CARBOHYDRATE COUNTING IN TYPE 1 DIABETES WITH AUTOMATED FASTER ASPART AND PRAMLINTIDE CLOSED-LOOP DELIVERY (ARTIFICIAL PANCREAS): A RANDOMIZED CONTROLLED TRIAL

Favorite
(DCP070) BETTER GLYCEMIC CONTROL WITH ONCE-WEEKLY INSULIN ICODEC VERSUS ONCE-DAILY INSULIN DEGLUDEC IN INSULIN-NAÏVE TYPE 2 DIABETES (ONWARDS 3)

Favorite
(DCP071) EUGLYCEMIC KETOACIDOSIS IN TYPE 1 DIABETES ON AN AUTOMATED INSULIN DELIVERY SYSTEM IMMEDIATELY AFTER BARIATRIC SURGERY: A CASE SERIES

Favorite
(DCP072) IDENTIFICATION OF PLAKOGLOBIN AS A NOVEL POSITIVE REGULATOR OF ADIPOGENESIS

Favorite
(DCP074) INCREASED PLASMA OXIDISED LOW-DENSITY APOLIPOPROTEIN B RESPONSIVENESS TO FLAXSEED LIGNAN COMPLEX IN OLDER TYPE 2 DIABETES PATIENTS THUS FAR FAILS TO DICTATE PLASMA C-REACTIVE PROTEIN REDUCTION

Favorite
(DCP075) LINOLEIC ACID-DERIVED OXYLIPIN SPECIES AND COGNITIVE FUNCTION IN TYPE 2 DIABETES MELLITUS

Favorite
(DCP076) LOW-DOSE EMPAGLIFLOZIN AS ADJUNCT TO HYBRID CLOSED-LOOP INSULIN THERAPY IN SUB-OPTIMALLY CONTROLLED ADULTS WITH TYPE 1 DIABETES: A RANDOMIZED CROSSOVER CONTROLLED TRIAL

Favorite
(DCP077) MEAL ENRICHED IN FRUCTOSE INCREASES INFLAMMATION WITHOUT INFLUENCING EXERCISE INFLAMMATORY RESPONSE IN MEN WITH TYPE 2 DIABETES

Favorite
(DCP078) METABOLOME-WIDE MENDELIAN RANDOMIZATION FOR YOUTH-ONSET TYPE 2 DIABETES

Favorite
(DCP079) PANCREATIC BETA-CELL FUNCTION AND ECTOPIC FAT DEPOSITION 9-18 MONTHS AFTER A MILD COVID-19 EPISODE

Favorite
(DCP080) THE ASSOCIATION BETWEEN THE CLINICAL PORTFOLIO DIET SCORE AND HBA1C IN TYPE 2 DIABETES MELLITUS: AN EXPLORATORY ANALYSIS OF TWO RANDOMIZED DIETARY TRIALS

Favorite